Advancing our innovative pipeline
to address unmet needs

Archived Publications

TransCon hGH

Once-Weekly TransCon hGH vs Daily hGH in Pediatric Growth Hormone Deficiency: The Phase 3 heiGHt Trial

E. Vlachopapadopoulou, E. Aghajanova, E. Chertok, M. Korpal-Szczyrska, E. Giorgadze,
T. Kovalenko, A. K. Maniatis, P. Thornton, P. Hofman, W. Song, A.D. Shu, D.B. Karpf, M. Beckert,
J.A. Leff. Presented at the 58th Annual European Society for Paediatric Endocrinology Meeting
(ESPE), September 19–21, 2019 (Vienna, Austria).

TransCon™ Growth Hormone in the Treatment of Pediatric Growth Hormone Deficiency: Results of the Phase 3 heiGHt Trial

P. Thornton, P. Hofman, A.K. Maniatis, E. Aghajanova, E. Chertok, M. Korpal-Szczyrska, E. Giorgadze, T. Kovalenko, A.D. Shu, D.B. Karpf, M. Beckert, J.A. Leff. Presented at the Endocrine Society (ENDO) Annual Meeting and Expo, March 23–26, 2019 (New Orleans, LA).

Baseline Demographics of the TransCon Growth Hormone Phase 3 heiGHt Trial

M. Beckert, D.B. Karpf, A. Shu, Z. Lin, J.A. Leff. Poster presented at the Endocrine Society (ENDO) Annual Meeting and Expo, March 17-20, 2018 (Chicago, IL).

Pediatric Phase 2 Data Demonstrate That TransCon hGH Has an Anti-hGH Immunogenic Profile That Is Comparable to Daily hGH

D. Gilfoyle, S. Pihl, P. Chatelain, M. Beckert. Poster presented at 55th Annual Meeting of the European Society for Paediatric Endocrinology (ESPE), September 10-12, 2016 (Paris, France).

A Six-Month Safety and Efficacy Study of TransCon hGH Compared to Daily hGH in Prepubertal Children with Growth Hormone Deficiency (GHD)

P. Chatelain, O. Malievsky, K. Radziuk, G. Senatorova, M. Beckert. Poster presented at 55th Annual Meeting of the European Society for Paediatric Endocrinology (ESPE), September 10-12, 2016 (Paris, France).

Design and Clinical Development of TransCon Growth Hormone for Growth Hormone Deficiency

M. Beckert, D. Gilfoyle, J.M. Mikkelsen, et al. Poster presented at 55th Annual Meeting of the European Society for Paediatric Endocrinology (ESPE), September 10-12, 2016 (Paris, France).

Pharmacokinetic Modelling Predicts Native hGH Levels Following Administration of a Sustained-release Prodrug, TransCon hGH, to Children With GHD

K. Sprogøe, M. Beckert, E.D. Christoffersen, D. Gilfoyle, T. Wegge. Poster presented at 55th Annual Meeting of the European Society for Paediatric Endocrinology (ESPE), September 10-12, 2016 (Paris, France).

TransCon PTH

TransCon PTH for Hypoparathyroidism – Design and Preliminary Results of a Phase 1 TransCon PTH Trial in Healthy Adults

D.B. Karpf, S. Pihl, E. Mortensen, K. Sprogøe, J.A. Leff. Poster presented at the Endocrine Society (ENDO) Annual Meeting and Expo, March 17-20, 2018 (Chicago, IL).

TransCon PTH, a Sustained Release PTH Analogue for the Treatment of Hypoparathyroidism – Proof-of-Principle in Monkeys and Tptx Rats

K.Sprogøe, L. Holten-Andersen, F. Cleeman, J. Zettler, S. Pihl, V.M. Breinholt. Poster presented at the Endocrine Society (ENDO) Annual Meeting and Expo, April 1-4, 2017 (Orlando, FL).

Pharmacokinetics of TransCon PTH, a Sustained-Release PTH Prodrug for Hypoparathyroidism, in Rat and Cynomolgus Monkey

K. Sprogøe, S. Pihl, C.E. Rasmussen, L. Holten-Andersen, F. Cleeman, V.M. Breinholt. Poster presented at the Endocrine Society (ENDO) Annual Meeting and Expo, April 1-4, 2017 (Orlando, FL).

TransCon CNP

TransCon CNP, a Sustained-Release Prodrug of C-Type Natriuretic Peptide, Effects Positive Bone Growth in Young Cynomolgus Monkeys and in a Mouse Model of Achondroplasia

V.M. Breinholt, N.Kaci, C.E. Rasmussen, O. Keil, S. Adermann, U. Hersel, M. Cornille, P. H. Mygind, K. Sprogøe, L. Legeai-Mallet. Poster presented at the Endocrine Society (ENDO) Annual Meeting and Expo, April 1-4, 2017 (Orlando, FL).

TransCon CNP, a Sustained-Release C-Type Natriuretic Peptide Analogue, for the Treatment of Achondroplasia

K. Sprogøe, C.E. Rasmussen, U. Hersel, V.M. Breinholt. Poster presented at the Endocrine Society (ENDO) Annual Meeting and Expo, April 1-4, 2017 (Orlando, FL).

Back to Top

You are about to access www.ascendispharma.us. The information on this website is intended for residents of the United States. Click below to confirm you are a citizen and/or resident of the United States.

Go

You are about to access www.ascendispharma.us. The information on this website is intended for residents of the United States. Click below to confirm you are a citizen and/or resident of the United States.

Go